Nils-Halvdan Morken

Professor Nils-Halvdan Morken is a distinguished researcher and clinician at the University of Bergen, Faculty of Medicine, Department of Clinical Science, and serves as a senior physician (Overlege) and researcher at Bergen Hospital Trust - Haukeland University Hospital, Women's Clinic.

His research primarily focuses on reproductive medicine, with particular emphasis on ovarian function, fertility assessment, pregnancy complications, and maternal-fetal health outcomes. His work often utilizes large population-based datasets from Norway, including the Medical Birth Registry and the Norwegian Mother, Father and Child Cohort Study (MoBa). He has conducted influential research on topics such as the timing of progesterone treatment for preterm birth prevention, the relationship between menarche and fertility, and health outcomes related to Down syndrome and congenital heart defects.

His recent publications demonstrate a strong focus on understanding factors affecting fertility, pregnancy outcomes, and long-term maternal health implications. His research often addresses health disparities, particularly among immigrant populations in Norway with studies on antenatal care utilization and ultrasound examination patterns.

• Norwegian Institute of Public Health funding for research on ovarian function and fertility
• Telemark Hospital Trust support for various reproductive health studies
• Research Council of Norway funding (projects 262700 and 320656)
• European Research Council funding (BIOSFER, 101071773)

Professor Morken actively leads significant research initiatives including 'Den norske populasjonsbaserte studien av for tidlig fødsel' (The Norwegian population-based study of preterm birth) and 'Den norske PrELOAD-studien' (The Norwegian PrELOAD study) at the University of Bergen, collaborating with researchers across multiple institutions.

His research group focuses on population-based studies of reproductive health, utilizing registry data and cohort studies to address important clinical questions with direct implications for improving women's healthcare in Norway.